VRCA short interest
Verrica Pharmaceuticals Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 196,221 |
|---|---|
| Change vs prior report | -6,534 (-3.2%) |
| Change over six months | -60.6% |
| Days to cover | 4.06 (sector: 3.78) |
| Average daily volume | 48,284 |
| Rank in Healthcare | not ranked (OTC, fund or thinly traded) |
VRCA short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 196,221 | -3.2% | 4.06 | 48,284 |
| 2026-09-15 | 202,755 | -8.9% | 4.18 | 48,525 |
| 2026-08-31 | 222,572 | -17.4% | 1.42 | 156,721 |
| 2026-08-14 | 269,349 | -6.4% | 5.16 | 52,177 |
| 2026-07-31 | 287,747 | -8.9% | 9.84 | 29,236 |
| 2026-07-15 | 315,760 | -2.8% | 11.07 | 28,529 |
| 2026-06-30 | 324,679 | -7.7% | 6.30 | 51,545 |
| 2026-06-15 | 351,818 | -7.2% | 9.26 | 37,985 |
| 2026-05-29 | 379,278 | -8.1% | 9.35 | 40,570 |
| 2026-05-15 | 412,480 | -29.1% | 3.56 | 115,949 |
| 2026-04-30 | 582,214 | +0.1% | 7.38 | 78,856 |
| 2026-04-15 | 581,329 | +16.8% | 6.81 | 85,374 |
| 2026-03-31 | 497,753 | +4.0% | 3.94 | 126,242 |
| 2026-03-13 | 478,579 | +18.2% | 3.16 | 151,325 |
| 2026-02-27 | 405,005 | +5.3% | 3.89 | 104,115 |
| 2026-02-13 | 384,580 | +13.8% | 2.38 | 161,889 |
| 2026-01-30 | 338,059 | +13.1% | 2.49 | 135,535 |
| 2026-01-15 | 299,006 | +2.3% | 1.89 | 158,352 |
| 2025-12-31 | 292,263 | -23.2% | 1.37 | 213,893 |
| 2025-12-15 | 380,561 | -26.2% | 1.38 | 275,400 |
| 2025-11-28 | 515,613 | +15.4% | 1.00 | 577,431 |
| 2025-11-14 | 446,691 | +6.4% | 6.84 | 65,333 |
| 2025-10-31 | 419,718 | +38.9% | 1.13 | 369,920 |
| 2025-10-15 | 302,200 | -29.4% | 1.04 | 290,724 |
| 2025-09-30 | 428,364 | +152.2% | 1.00 | 825,577 |
import finzdata as yf
yf.Ticker("VRCA").short_interest # every report since 2017
yf.Client().short_interest(["VRCA"], start="2018-01-01")Healthcare short interest · VRCA price history · Who owns VRCA · All short interest